Search
Română
Magyar
English
Français
Deutsch
Italiano
Español
Русский
日本語
中国人
Change Language
Română
Magyar
English
Français
Deutsch
Italiano
Español
Русский
日本語
中国人
Sections
News
Exclusive
INSCOP Surveys
Podcast
EU
Diaspora
Republic of Moldova
Politics
Economy
Current Affairs
International
Sport
Health
Education
IT&C knowledge
Arts & Lifestyle
Opinions
Elections 2025
Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
News
Exclusive
INSCOP Surveys
Podcast
EU
Diaspora
Republic of Moldova
Politics
Economy
Current Affairs
International
Sport
Health
Education
IT&C knowledge
Arts & Lifestyle
Opinions
Elections 2025
Environment
11 events about "AstraZeneca"
9 July 2026, 14:05
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
International
24 February 2026, 17:39
Pascal Soriot, the CEO of AstraZeneca, was paid £17.7 million in 2025. There is a possibility that in 2026 he will earn approximately £20 million.
Current Affairs
10 February 2026, 13:23
AstraZeneca recorded a net profit of 10.2 billion dollars in 2025, with a 45% increase due to sales of cancer drugs.
International
11 October 2025, 08:16
AstraZeneca has announced significant reductions for medications sold in the United States, following an agreement made with the Trump administration.
International
6 October 2025, 12:44
AstraZeneca has signed a 555 million dollar agreement with Algen for the development of therapies based on Crispr technology, specialized in artificial intelligence.
Economy
30 September 2025, 09:18
AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
International
14 September 2025, 06:12
AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.
Economy
23 July 2025, 08:20
AstraZeneca will invest 50 billion dollars to expand manufacturing and research in the US, including a new plant in Virginia for anti-obesity treatments.
International
3 July 2025, 08:05
AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Economy
2 June 2025, 06:41
An experimental pill from AstraZeneca has shown a 56% reduction in the risk of breast cancer progression, according to a study presented at ASCO
Health
19 March 2024, 12:18
AstraZeneca is buying Fusion Pharmaceuticals, a Canadian company specializing in radioconjugation cancer treatments, for $2.4 billion.
Health
Editor’s Recommendations
International
6 hours ago
The Russian press omitted references to Moscow in Nicușor Dan's message about the downed drone.
Current Affairs
2 hours ago
Petrișor Peiu: "A firm protest against Russia is necessary every time Russian drones enter our airspace."
Opinions
14 hours ago
Sever Voinescu, Dilema.ro: He says it's a mirror, not a conscience
Exclusive
Yesterday 09:15
Original Content
IT News Review by Control F5 Software: The United Kingdom proposes a voluntary nighttime restriction for social networks
Personalized news feed, AI-powered search, and notifications in a more interactive experience.